Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial. (Q35030247)
Jump to navigation
Jump to search
scientific article published on 27 January 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial. |
scientific article published on 27 January 2015 |
Statements
Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial (English)
Jon Iredell
Spiros Miyakis
Tiffany Harris-Brown
27 January 2015
27 January 2015
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference